Test Price
950 AED✅ Home Collection Available
Menorrhagia Screen Test in UAE | 950 AED | DHA Licensed
Executive Summary & Core Metrics
Key Highlights
- Diagnostic Sensitivity: 99.9% via electromechanical & photo‑optical dual detection
- Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Daily 8 AM – 11 PM)
- Post‑Test Support: Tele‑consultation with licensed physicians for result interpretation
- Insurance: Direct verification and billing with major UAE insurers via WhatsApp
* Next‑day turnaround for samples received by Thursday 11 AM
Test Overview & Methodology
The Menorrhagia Screen Test is a comprehensive coagulation panel designed to identify underlying bleeding disorders in patients with heavy menstrual bleeding. It utilizes electromechanical and photo‑optical clot detection for precise diagnosis, including PT, aPTT, fibrinogen, and platelet function screening.
| Feature | Menorrhagia Screen (Our Test) | Standard Coagulation Panel |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity via electromechanical & photo‑optical dual detection | Variable; often manual or semi‑automated |
| Methodology | Electromechanical & photo‑optical clot detection | Optical or mechanical clot detection; limited to PT/aPTT |
| Turnaround Time | Next‑day report (sample received by Thu 11 am) | 2–3 working days |
| Price | 950 AED (inclusive of home collection) | 600–800 AED (lab visit only) |
| DHA Accreditation | Facility License 1143; ISO 9001:2015 certified | May vary |
Physician Insight & Safety Protocols
“The Menorrhagia Screen is a critical first step in evaluating underlying coagulopathies such as von Willebrand disease. However, results must be interpreted in the context of clinical history and physical examination. Always correlate with bleeding assessment tools.” — Dr. Ajay Singh (DHA License: 36234132)
⚠️ Medication Advisory & Patient Preparation
Do not discontinue prescribed medication without consulting your doctor. Patients on anticoagulants must follow pre-test guidelines:
- Discontinue Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling, only with prior consent from your treating physician.
- Overnight fasting (8–12 hours) is preferred.
- A duly filled Coagulation Requisition Form (Form 15) is mandatory.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active hemorrhagic shock, ongoing massive hemorrhage requiring immediate hospitalization, inability to provide informed consent, contraindication to venipuncture.
- Red Flags — Seek Emergency Care Immediately: Soaking more than 2 heavy pads per hour for 2 consecutive hours, dizziness or fainting, chest pain, palpitations, severe pallor, or shortness of breath.
- Do not attempt home collection if you experience any of these symptoms. Call 998 for ambulance.
Patient FAQ & Clinical Guidance
1. What is the Menorrhagia Screen Test and why is it recommended for heavy periods?
The Menorrhagia Screen identifies coagulation defects such as von Willebrand disease, which is common in heavy menstrual bleeding. It provides a precise diagnosis that enables personalized treatment plans and specialist referrals.
2. What preparation is required before the blood draw?
Observe overnight fasting (8–12 hours) and complete the mandatory Coagulation Requisition Form. Stop heparin 1 day and oral anticoagulants 7 days before sampling, only with your doctor's approval. Our phlebotomist will manage all cold‑chain logistics during the home visit.
3. How quickly will I get my results and how does insurance work?
Results are delivered the next day when the sample reaches the lab by Thursday 11 AM. We provide direct billing with major UAE insurers and real‑time eligibility checks via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Patient data is encrypted and handled in strict confidence.
Clinical & Logistical Metadata
| Test Name | Menorrhagia Screen Test |
| Price (AED) | 950 AED |
| Turnaround Time | Next day (sample received by Thursday 11 AM) |
| Sample Type / Matrix | Whole Blood (Sodium Citrate) |
| Methodology Used | Electromechanical & Photo‑Optical Clot Detection |
| ICD-10-CM Code | N92.0 (Excessive and frequent menstruation with regular cycle) |
| LOINC Code | 34579-9 (Coagulation panel - Blood) |
| DHA Facility License & Lab Address | License No. 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians